Mergers and Acquisitions
QIAGEN Acquires Genoox to Boost AI-Driven Genomic Interpretation for Clinical Labs Globally
Acquisition adds Franklin solution, an AI-powered cloud platform for clinical decision support in genetic diseases Strengthens QIAGEN Digital Insights...
May 13, 2025 | News
Waters Integrates MALS into Empower™ Software to Accelerate Biologics QC and Slash Validation Time
Saves up to six months on compliant software validation in biopharmaceutical quality control. Reduces analysis time for biotherapeutic peptides and prot...
May 07, 2025 | News
PCI Pharma Services Acquires Ajinomoto Althea’s Altair to Build Global Powerhouse in Aseptic Filling and Advanced Drug Delivery
PCI Pharma Services ("PCI") is pleased to announce the launch of Ajinomoto Althea, the world's leading contract research and manufacturing organi...
May 05, 2025 | News
Merck to Acquire SpringWorks Therapeutics for $3.9 Billion, Strengthening Rare Tumor Leadership
Purchase price of $47 per share in cash represents an enterprise value of €3.0 billion ($3.4 billion), or an equity value of approximately $3.9 bill...
April 28, 2025 | News
Suvoda and Greenphire Merge to Create Unified Platform for Streamlining Clinical Trials
Suvoda, a global clinical trial technology company specializing in randomization and trial supply management, consent, and patient outcomes data collection...
April 25, 2025 | News
Norgine to Acquire Theravia, Strengthening Its Rare Disease Portfolio Across Europe
Norgine and Theravia announced that they have entered into a definitive agreement under which Norgine will acquire Theravia, an international pharmace...
April 17, 2025 | News
Rege Nephro Acquires Tamibarotene Assets from Syros Pharmaceuticals to Advance ADPKD Program
Rege Nephro Co., Ltd. (Headquarter: Kyoto, Japan; Chief Executive Officer: Akifumi Morinaka) has announced that it has successfully acquired Tami...
April 16, 2025 | News
Turn Bio Acquires ARMMs Technology to Advance Precision Epigenetic Therapies Across More Tissues and Indications
ARMMs brings precision medicine through targeted, non-viral vesicular delivery Synergy of ARMMs and eTurna™ LNP platforms means company can delive...
March 27, 2025 | News
Azurity Pharmaceuticals Completes Acquisition of Covis Group, Expanding Global Footprint and Therapeutic Portfolio
Azurity Pharmaceuticals ("Azurity") announced the successful completion of its acquisition of Covis Group S.à r.l. ("Covis") from e...
March 17, 2025 | News
MasterControl Acquires Qualer to Integrate Asset Management into Life Sciences Quality and Manufacturing Platform
MasterControl, a leading provider of quality and manufacturing software solutions for life sciences, announced the acquisition of Qualer, a cloud-native as...
March 04, 2025 | News
WuXi XDC Expands Partnership with LigaChem to Accelerate Next-Gen ADC Development
WuXi XDC Cayman Inc. ("WuXi XDC", or the "Company", stock code: 2268.HK), a leading global CRDMO (Contract Research, Development, and Manufacturing Organiz...
February 26, 2025 | News
Thermo Fisher Scientific to Acquire Solventum’s Purification & Filtration Business for $4.1 Billion in Cash
Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, announced that the company has en...
February 25, 2025 | News
Telix Pharmaceuticals Completes Acquisition of ImaginAb’s Next-Gen Therapeutic Pipeline and Biologics Platform
Telix Pharmaceuticals Limited announces it has completed the acquisition from antibody engineering company ImaginAb, Inc. (ImaginAb). The acquisition inclu...
January 31, 2025 | News
Telix Pharmaceuticals Completes Acquisition of RLS Radiopharmacies to Strengthen U.S. Radiopharmaceutical Footprint
Telix Pharmaceuticals Limited announces it has completed the acquisition of RLS (USA) Inc. (RLS; RLS Radiopharmacies), America's only Joint Commission-accr...
January 28, 2025 | News
Most Read
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Top 25 Biotech & Biopharma Leaders in Sustainable Innovation, 2025
- China’s Biopharma Dealmaking Surges in H1 2025, Driven by Record Licensing and Oncology Focus
- Chikungunya in China: How a “Forgotten” Arbovirus Found the Perfect Storm
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
